Download FREE Report Sample
Download Free sampleRilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle?Wells syndrome; deficiency of interleukin-1 receptor antagonist; and recurrent pericarditis.
Rilonacept Drugs Market contains market size and forecasts of Rilonacept Drugs in global, including the following market information:
Global Rilonacept Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rilonacept Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Rilonacept Drugs companies in 2021 (%)
The global Rilonacept Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lyophilized Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rilonacept Drugs include Kiniksa. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the Rilonacept Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rilonacept Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rilonacept Drugs Market Segment Percentages, by Type, 2021 (%)
Lyophilized
Liquid
Global Rilonacept Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rilonacept Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Other
Global Rilonacept Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rilonacept Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rilonacept Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rilonacept Drugs revenues share in global market, 2021 (%)
Key companies Rilonacept Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Rilonacept Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kiniksa
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
